Drug treatments for managing cystic fibrosis-related diabetes-Reference-Cited by-同舟云学术

Drug treatments for managing cystic fibrosis-related diabetes

Published:2020-10-19 Issue:10 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Onady Gary M¹,Stolfi Adrienne²

Affiliation:

1. Boonshoft School of Medicine; Wright State University; Dayton Ohio USA

2. Department of Pediatrics; Children's Medical Center; Dayton Ohio USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference71 articles.

1. Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus;Ballmann;BMC Pediatrics,2014

2. Repaglinide versus insulin in the treatment of CFRD diagnosed by screening: an open prospective randomized study;Ballmann;Pediatric Pulmonology,2013

3. Treatment of early diagnosed CFRD with oral drugs verus insulin: An open prospective randomized study;Ballmann;Journal of Cystic Fibrosis,2013

4. Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial;Ballmann;The Lancet Diabetes and Endocrinology,2018

5. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test;Schmid;Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Changing Landscape of Treatment for Cystic Fibrosis Related Diabetes;Journal of Clinical & Translational Endocrinology;2024-03

2. ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis;Clinical Nutrition;2024-02

3. Effects of modulator therapies on endocrine complications in adults with cystic fibrosis: a narrative review;Medical Journal of Australia;2023-10-15

4. Oxidative Stress Biomarkers in Cystic Fibrosis and Cystic Fibrosis-Related Diabetes in Children: A Literature Review;Biomedicines;2023-09-29

5. Continuous Glucose Monitoring as an Additional Tool in Early Cystic Fibrosis-Related Diabetes Monitoring and in Evaluation of Short-Term Sitagliptin Response;Biomedicines;2023-06-19